关注
Aditi Shah
Aditi Shah
Analysis Group
在 analysisgroup.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Assessment of Various Risk Factors for Success of Delayed and Immediate Loaded Dental Implants: A Retrospective Analysis.
MC Prasant, R Thukral, S Kumar, SM Sadrani, H Baxi, A Shah
The journal of contemporary dental practice 17 (10), 853-856, 2016
222016
Long-term psoriasis control with guselkumab, adalimumab, secukinumab, or ixekizumab in the USA
T Fitzgerald, M Zhdanava, D Pilon, A Shah, A Hilts, P Lefebvre, ...
Dermatology and Therapy 13 (4), 1053-1068, 2023
142023
Incidence of cardiometabolic outcomes among people living with HIV‐1 initiated on integrase strand transfer inhibitor versus non‐integrase strand transfer inhibitor …
PF Rebeiro, B Emond, C Rossi, BK Bookhart, A Shah, G Caron‐Lapointe, ...
African Journal of Reproduction and Gynaecological Endoscopy 26 (6), e26123, 2023
122023
Comparison of prostate-specific antigen response in patients with metastatic castration-sensitive prostate cancer initiated on apalutamide or abiraterone acetate: A …
B Lowentritt, D Pilon, D Waters, C Rossi, E Muser, S Kurteva, A Shah, ...
Urologic Oncology: Seminars and Original Investigations 41 (5), 252. e19-252 …, 2023
122023
Association between weight gain and the incidence of cardiometabolic conditions among people living with HIV-1 at high risk of weight gain initiated on antiretroviral therapy
GA McComsey, B Emond, A Shah, BK Bookhart, C Rossi, K Milbers, ...
Infectious Diseases and Therapy 11 (5), 1883-1899, 2022
122022
Characteristics of real-world commercially insured patients with treatment-resistant depression initiated on esketamine nasal spray or conventional therapies in the United States
S Karkare, M Zhdanava, D Pilon, AI Nash, L Morrison, A Shah, P Lefebvre, ...
Clinical Therapeutics 44 (11), 1432-1448, 2022
92022
Understanding the health system conditions affecting the use of long-acting injectable antipsychotics in the treatment of schizophrenia in clinical practice: a US healthcare …
M Zhdanava, HL Starr, P Lefebvre, TI Totev, A Shah, K Sheng, D Pilon
Neuropsychiatric Disease and Treatment, 1479-1493, 2022
92022
Treatment patterns, healthcare utilization, and costs of patients with treatment-resistant depression initiated on esketamine intranasal spray and covered by US commercial …
K Joshi, D Pilon, A Shah, C Holiday, S Karkare, M Zhdanava
Journal of Medical Economics 26 (1), 422-429, 2023
82023
Impact of COVID-19 pandemic on prescribing of long-acting injectable antipsychotics for schizophrenia: results from a United States prescriber survey
M Zhdanava, HL Starr, TI Totev, P Lefebvre, A Shah, K Sheng, D Pilon
Neuropsychiatric Disease and Treatment, 2003-2019, 2022
72022
Esketamine nasal spray for major depressive disorder with acute suicidal ideation or behavior: description of treatment access, utilization, and claims-based outcomes in the …
M Zhdanava, A Teeple, D Pilon, A Shah, G Caron-Lapointe, K Joshi
Journal of Medical Economics 26 (1), 691-700, 2023
52023
Real-world weight changes in people with HIV-1 at risk of weight gain (female, Black or Hispanic) switching from integrase strand transfer inhibitors
P Donga, B Emond, A Shah, BK Bookhart, D Anderson, ...
Journal of Comparative Effectiveness Research 12 (1), e220147, 2023
42023
Risk of treatment discontinuation among patients with psoriasis initiated on ustekinumab and other biologics in the USA
D Pilon, T Fitzgerald, M Zhdanava, A Teeple, L Morrison, A Shah, ...
Dermatology and Therapy 12 (4), 971-987, 2022
42022
Response to the letter to the editor: long-term psoriasis control with guselkumab, adalimumab, secukinumab, or ixekizumab in the USA
T Fitzgerald, M Zhdanava, D Pilon, A Shah, P Lefebvre, SR Feldman
Dermatology and Therapy 13 (11), 2917-2923, 2023
22023
Comparative analysis of persistence and remission with guselkumab versus secukinumab and ixekizumab in the United States
M Zhdanava, T Fitzgerald, D Pilon, RE Teneralli, A Shah, L Diaz, ...
Journal of Dermatological Treatment 35 (1), 2349658, 2024
12024
Real-World Maintenance Phase Persistence on Ustekinumab and Adalimumab in Ulcerative Colitis
M Zhdanava, S Kachroo, A Shah, Z Ding, P Lefebvre, R Zhao, C Kerner, ...
Patient preference and adherence, 809-820, 2024
12024
Real-world long-term persistence and surgical procedure-free period among bio-naïve patients with Crohn’s disease and fistula initiated on Ustekinumab
M Zhdanava, S Kachroo, P Boonmak, S Burbage, A Shah, P Lefebvre, ...
Advances in Therapy 41 (10), 3922-3933, 2024
12024
S83 Real-World Treatment Persistence Among Advanced Therapy-Experienced Patients With Ulcerative Colitis Initiated on Ustekinumab or Adalimumab
M Zhdanava, S Kachroo, P Boonmak, S Burbage, A Shah, J Korsiak, ...
Official journal of the American College of Gastroenterology| ACG 118 (12S), S23, 2023
12023
A Cross-Sectional Study of Patient Out-of-Pocket Costs for Antipsychotics Among Medicaid Beneficiaries with Schizophrenia
D Lin, D Pilon, L Morrison, A Shah, MH Lafeuille, P Lefebvre, C Benson
Drugs-Real World Outcomes 10 (3), 471-480, 2023
12023
Real-world ustekinumab persistence in patients with ulcerative colitis attaining the maintenance phase
M Zhdanava, S Kachroo, A Shah, Z Ding, C Holiday, P Lefebvre, R Zhao, ...
Gastroenterology 164 (4), S46-S47, 2023
12023
Indian central cotton committee: Studies in the physiology of the broch cotton plant
KV Joshi, RB Gode, AK Shah
Indian Central Cotton Committee, Bombay, 1941
11941
系统目前无法执行此操作,请稍后再试。
文章 1–20